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rbB2 is a receptor tyrosine kinase belonging to the
family of epidermal growth factor (EGF) receptors
which is generally involved in cell differentiation,
 
proliferation, and tumor growth, and activated by het-
erodimerization with the other members of the family. We
 
show here that type IV pilus–mediated adhesion of 
 
Neisseria
 
meningitidis
 
 onto endothelial cells induces tyrosyl phos-
phorylation and massive recruitment of ErbB2 underneath
 
the bacterial colonies. However, neither the phosphorylation
status nor the cellular localization of the EGF receptors,
ErbB3 or ErbB4, were affected in infected cells. ErbB2
phosphorylation induced by 
 
N. meningitidis
 
 provides
docking sites for the kinase src and leads to its subsequent
E
 
activation. Speciﬁc inhibition of either ErbB2 and/or src
activity reduces bacterial internalization into endothelial
cells without affecting bacteria-induced actin cytoskeleton
reorganization or ErbB2 recruitment. Moreover, inhibition
of both actin polymerization and the ErbB2/src pathway
totally prevents bacterial entry. Altogether, our results pro-
vide new insight into ErbB2 function by bringing evidence
of a bacteria-induced ErbB2 clustering leading to src kinase
phosphorylation and activation. This pathway, in cooperation
 
with the bacteria-induced reorganization of the actin
cytoskeleton, is required for the efﬁcient internalization of
 
N. meningitidis
 
 into endothelial cells, an essential process
enabling this pathogen to cross host cell barriers.
 
Introduction
 
The ErbB family of receptor tyrosine kinases (RTKs)* com-
prises four closely related members: EGF receptor (EGFR;
also termed ErbB1), ErbB2/Neu, ErbB3, and ErbB4. These
receptors are activated by numerous ErbB-specific ligands,
each containing an EGF-like domain which confers binding
specificity (for review see Olayioye et al., 2000). These
ligands, which are produced as transmembrane precursors
and are processed and released by proteolysis, bind the extra-
cellular domain of ErbB receptors and lead to the formation
of both homo- and heterodimers. No soluble ligand for
ErbB2 has yet been discovered. However, increasing evi-
dence suggests that the primary function of ErbB2 is as a
coreceptor, since ErbB2 is the preferred heterodimerization
partner for all other ErbB family members (Tzahar et al.,
1996; Graus-Porta et al., 1997) and plays a role in the po-
tentiation of ErbB receptor signaling (Beerli et al., 1995;
Graus-Porta et al., 1995). Dimerization stimulates the in-
trinsic tyrosine kinase activity of the receptors and triggers
autophosphorylation of specific tyrosine residues within the
cytoplasmic domains. These phosphorylated residues pro-
vide docking sites for proteins which contain src homology 2
(SH2) or phosphotyrosine binding domains and which are
involved in the regulation of intracellular signaling cascades.
All ErbB family members couple via the adaptors Shc and/or
Grb2 to the mitogen-activated protein kinase (MAPK) path-
way. However, preferential modulation of specific pathways
linked to specific homo- or heterodimers, or to specific cell
surface sites, have been described (Olayioye et al., 2000;
Carraway and Sweeney, 2001). Therefore, the signaling di-
versity associated with the ErbB family is dependent upon
the repertoire of ErbB ligands, the combinatorial properties
of induced receptor dimers, and receptor localization. Ulti-
mately, downstream effects on gene expression determine
the biological response to receptor activation. ErbB recep-
tors are expressed in a variety of tissues of epithelial, mesen-
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chymal, and neuronal origin, where they play fundamental
roles in development, proliferation, and differentiation. Re-
cently, an expression of ErbB receptors has also been
described on endothelial cells, where they play a role in an-
giogenesis (Russell et al., 1999). Moreover, deregulated ex-
pression of ErbB receptors, in particular ErbB1 and ErbB2,
has been implicated in the development and malignancy of
numerous types of human cancers (Yarden and Sliwkowski,
2001). ErbB2 overexpression, observed in a significant pro-
portion of breast and ovarian cancers, triggers ligand-inde-
pendent activation of the kinase domain, apparently as a re-
sult of spontaneous dimer formation. A ligand-independent
activation of ErbB RTKs can also be triggered by other
classes of receptors, such as G protein–coupled receptors, cy-
tokine receptors, or adhesion molecules (Carpenter, 1999;
Gschwind et al., 2001). In the absence of ErbB kinase activ-
ity, phosphorylation of specific tyrosyl residues in the cyto-
plasmic tail of the receptor by nonreceptor kinases such as
jak or src can provide docking sites for cytoplasmic signaling
molecules and promote signaling cascades. In addition, a
ligand-dependent transactivation of EGFR by G protein–
coupled receptors can also occur by a proteolytic processing
of the transmembrane pro-HB-EGF precursor followed by
a paracrine activation of EGFR (Gschwind et al., 2001).
Therefore, ErbB RTKs are central signal transducers which
respond to the binding of specific ligands or via transactiva-
tion by distinct receptor systems.
Many bacterial pathogens exploit host cell signaling path-
ways in order to promote their adherence to or uptake by
host cells (Dramsi and Cossart, 1998). For most invasive
bacteria, a major consequence of these signaling events is a
morphological change of the host cell surface resulting from
a reorganization of the actin cytoskeleton. The nature and
magnitude of such changes depend highly on the pathogen
and its cellular host, although a common feature is the acti-
vation of host tyrosine phosphorylation leading to the acti-
vation of the small GTPases of the Rho family, key regu-
lators of actin cytoskeleton dynamics. The best studied
examples are those of 
 
Shigella
 
 or
 
 Salmonella
 
 which trigger
the induction of large cellular membrane folds or ruffles
around bacteria leading to their subsequent uptake by a
macropinocytic process (Nhieu and Sansonetti, 1999; Galan
and Zhou, 2000). These pathogens have evolved a complex
type III secretion system allowing them to inject into host
cells bacterial components that can directly initiate the acti-
vation of cellular signaling cascades. Alternatively, 
 
Listeria
monocytogenes
 
, which does not have a type III secretion sys-
tem, promotes its entry by engaging cell adhesion receptors
(E-cadherins) and the tyrosine kinase receptor Met (Men-
gaud et al., 1996; Shen et al., 2000).
 
Neisseria
 
 
 
meningitidis
 
 (also referred to as meningococcus)
is an extracellular, human-specific pathogen responsible for
septicemia and meningitis. Despite the lack of type III secre-
tion system, virulent capsulated 
 
N. meningitidis
 
 also initiates
host cell signaling cascades leading to their subsequent up-
take into host cells that are normally nonphagocytic (Nassif
et al., 1999; Merz and So, 2000). This entry is likely to pro-
mote their transcytosis through cellular barriers by a mecha-
nism that remains to be clearly identified, and therefore
plays a major role in bacterial pathogenesis. Capsulated 
 
N.
meningitidis
 
 interact with host cells in a multistep process
(Pujol et al., 1997). Bacteria first adhere through their type
IV pili, which are long filamentous protein structures that
interact with an unidentified cellular receptor. Bacteria then
proliferate, locally forming a colony at their site of attach-
ment on the cell surface, a step referred to as localized adhe-
sion. Subsequently, bacteria loose their pili, disperse from
the colony, and spread over the cell surface to form a single
monolayer of bacteria covering the cells, a step referred to as
diffuse adhesion. The bacterial protein PilT, which is re-
sponsible for pilus retraction (Merz et al., 2000), is required
for the transition from localized to diffuse adhesion (Pujol et
al., 1999). Internalization of these bacteria occurs essentially
during the first step of localized adhesion. During this inter-
action, 
 
N. meningitidis
 
 adhering to epithelial cells elicits the
formation of specific molecular complexes underneath the
bacterial colonies. These structures, called cortical plaques,
result from the localized polymerization of cortical actin, re-
cruitment of ezrin, a protein that links the cellular mem-
brane to the actin cytoskeleton, and clustering of membrane
integral proteins, such as the ezrin binding proteins CD44
or ICAM-1 as well as tyrosine phosphorylated proteins
(Merz and So, 1997; Merz et al., 1999). These events are ac-
companied by the elongation of the epithelial cell microvilli
towards the bacteria, leading to their engulfment and inter-
nalization into host cells. We recently showed that 
 
N. men-
ingitidis
 
 interaction with endothelial cells also leads to corti-
cal actin polymerization underneath the bacterial colonies
and the massive recruitment of ezrin and ezrin-binding pro-
teins (unpublished data). This recruitment promotes the for-
mation of membrane projections, reminiscent of epithelial
microvilli structures, which surround single bacteria and
provoke their internalization within endothelial intracellular
vacuoles. This has been demonstrated both in vitro and in
vivo and suggests that this process is essential for the crossing
of human endothelium via a transcytosis pathway. We fur-
ther showed that 
 
N. meningitidis
 
–induced actin polymeriza-
tion requires the activation of the small GTPases of the Rho
family RhoA and Cdc42, but not Rac1. Inhibition of Rho
family GTPases prevented cortical actin polymerization, but
only partially inhibited bacterial internalization, suggesting
an alternative signaling pathway involved in 
 
N. meningitidis
 
internalization. The process by which 
 
N. meningitidis
 
 inter-
acts with the host cell and induces these signaling events has
not been elucidated.
In this study, we therefore analyzed the tyrosine phos-
phorylation events occurring in human endothelial cells dur-
ing adhesion of 
 
N. meningitidis
 
. We provide evidence that
pilus-mediated adhesion of capsulated 
 
N. meningitidis
 
 in-
duces the clustering and tyrosyl phosphorylation of the host
cell tyrosine kinase receptor ErbB2, but not of the other
ErbBs. ErbB2 activation leads to downstream activation of
the protein tyrosine kinase src and the tyrosine phosphoryla-
tion of the src-substrate cortactin. Furthermore, we show
that ErbB2/src signaling pathway is not involved in the for-
mation of cortical plaques per se, but plays a crucial role in
facilitating bacterial entry into endothelial cells. By analyz-
ing the respective contributions to bacterial entry of both
ErbB2/src and Rho GTPases–dependent signaling path-
ways, we show that ErbB2/src pathway regulates 
 
N. menin- 
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gitidis
 
 entry through signaling events distinct from those
leading to bacteria-induced actin cytoskeleton reorganiza-
tion. Moreover, both pathways cooperate in bacterial entry.
Therefore, our results provide evidence for a new mode of
activation of ErbB2 by bacteria-induced homodimerization,
and for a novel biological function of ErbB2 in supporting
bacterial internalization into host cells.
 
Results
 
Adhesion of 
 
N.
 
 
 
meningitidis
 
 to human endothelial cells 
induces tyrosine phosphorylation of cellular proteins, 
which can be prevented by AG1478, an ErbB
family inhibitor
 
We investigated the tyrosine phosphorylation events occur-
ring in a human endothelial cell line (HBMEC) during in-
teraction with 
 
N.
 
 
 
meningitidis. 
 
For this purpose, HBMECs
were infected with a piliated capsulated strain of 
 
N.
 
 
 
menin-
gitidis 
 
(wild-type 2C43), and two derivative mutants of that
strain: a highly piliated and adhesive mutant (PilT
 
 
 
) and a
nonpiliated (nonadherent) PilE
 
 
 
 mutant. As shown in Fig. 1
A, infection with the wild-type strain 2C43 for 4 h induced
the major tyrosyl phosphorylation of proteins of 
 
 
 
80/85
and 180 kD. These phosphorylation events were markedly
increased when cells were infected with the PilT
 
 
 
 mutant
of 2C43, whereas they were not observed in cells in con-
tact with the nonadherent PilE
 
 
 
 mutant. Kinetics analysis
showed that these signals were detectable as soon as 30 min
after infection, maximal at 4 h (during the pilus-mediated
localized adhesion). By contrast, they were no longer de-
tected at 8 h with the wild-type strain (diffuse adhesion),
whereas the signal remained persistent in cells infected with
the PilT
 
 
 
 mutant, which is unable to retract pili and to pro-
ceed to the diffuse adhesion step (unpublished data). There-
fore, these events occur during the localized pilus-mediated
adhesion of 
 
N. meningitidis
 
 to human endothelial cells. In
parallel, experiments were performed with an isolate of a
highly virulent strain, designated as ROU, obtained from
the cerebrospinal fluid of a patient with fulminant meningo-
coccal infection (Fig. 1 B). This strain was highly efficient in
inducing tyrosyl phosphorylation of the p80/85 and p180,
suggesting a correlation between these cellular events and
the infectious process of 
 
N. meningitidis
 
. Moreover, similar
data were observed with a primary culture of human umbili-
cal vein endothelial cells (unpublished data), suggesting that
these phosphorylation events might be a general response of
endothelial cells to 
 
N. meningitidis
 
 adhesion.
Since ErbB receptors are 
 
 
 
180 kD, compatible with that
of p180, we hypothesized that tyrosine kinase receptors of
the EGFR family might be involved in the cellular response
to bacterial adhesion. We tested whether these phosphoryla-
tion events would be affected by AG1478, a very potent and
selective inhibitor of both EGFR and ErbB2 kinases
(Kurokawa et al., 2000). As shown in Fig. 1 C, cell treat-
ment with 5 or 10 
 
 
 
M AG1478 totally prevented the in-
crease of tyrosyl phosphorylation of p180 protein induced
by either EGF or infection for 4 h with the PilT
 
 
 
 mutant,
whereas cell treatment with 10 
 
 
 
M AG1296, a selective in-
hibitor of the PDGF receptor kinase, had no effect. Simi-
larly to EGF, 
 
N.
 
 
 
meningitidis 
 
induced the activation of
the MAPK Erk1/2 that was also prevented by treatment
with AG1478, but not by AG1296. Altogether, these data
strongly suggest that the infection by 
 
N.
 
 
 
meningitidis 
 
leads to
the activation of member(s) of the ErbB family. Interest-
ingly, AG1478 treatment also drastically reduced the phos-
phorylation of p80/85 induced by 
 
N. meningitidis
 
, suggest-
ing these proteins as downstream targets of ErbB signaling
cascade. However, phosphorylation of p80/85 was not ob-
served in response to EGF stimulation.
 
Adhesion of 
 
N.
 
 
 
meningitidis
 
 to human endothelial cells 
induces tyrosine phosphorylation and clustering of 
ErbB2, but not of the other ErbB members
 
Therefore, we analyzed the tyrosyl phosphorylation state of
members of the ErbB family in cells infected for 4 h with ei-
ther the 2C43 wild-type, the PilT
 
 
 
 mutant, or the ROU
strain in the presence or in the absence of 5 
 
 
 
M AG1478.
Stimulation of HBMECs with EGF at 10 ng/ml for 3 min
Figure 1. Localized adhesion of N. meningitidis induces tyrosine 
phosphorylation events that are prevented by AG1478 treatment. 
(A) HBMECs (starved for 18 h) were either uninfected ( ) or 
infected with the wild-type strain (WT), the PilT-defective mutant 
(PilT
 ), or the PilE-defective mutant (PilE
 ) of the 2C43 strain of 
N. meningitidis for 4 h before lysis. (B) HBMECs starved for 18 h 
were either uninfected ( ) or infected with the 2C43 wild-type 
strain (WT) or ROU strain (ROU). (C) HBMECs (starved for 18 h) 
were pretreated for 2 h with 5 or 10  M AG1478, 10  M AG1296, 
or left untreated ( ). Cells were then infected for 4 h with the PilT-
defective mutant strain in the presence of these inhibitors before 
lysis. As control, cells pretreated the same way were stimulated with 
10 ng/ml EGF for 3 min before lysis. (A–C) Samples of whole cell 
extracts were analyzed by immunoblotting with an antiphosphoty-
rosine antibody (4G10). The electrophoretic mobilities of proteins of 
80/85 and 180 kD (arrows) and of molecular weight standards (175, 
116, 84, and 58 kD) are indicated. (C) Bottom, blot was reprobed 
with an antiphosphoErK1/2 antibody, which detects Erk1/2 when 
activated by phosphorylation. 
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highly stimulated EGFR tyrosine phosphorylation as ex-
pected, whereas 
 
N.
 
 
 
meningitidis 
 
adhesion had no effect on
tyrosine phosphorylation of the EGFR (Fig. 2 A). Analysis
of not only EGFR, but also ErbB3 or ErbB4 phosphor-
ylation over several hours of infection by 
 
N. meningitidis
 
failed to reveal any modification (unpublished data). By
contrast, bacterial infection induced tyrosyl phosphorylation
of ErbB2, which could be prevented by AG1478 treatment
(Fig. 2), indicating that 
 
N. meningitidis
 
 leads to the selective
activation of ErbB2, whereas EGF stimulated both EGFR
and ErbB2 phosphorylation, consistent with EGFR/ErbB2
heterodimerization (Fig. 2 C).
Therefore, cellular localization of the ErbB receptors was
analyzed in cells infected for 4 h with the 2C43 wild-type
strain
 
. 
 
As shown in Fig. 3, although ErbB2 displayed a
punctuated staining in uninfected cells, it was highly re-
cruited underneath the bacterial colonies in infected cells,
whereas EGFR, ErbB3, and ErbB4 staining was not af-
fected. Altogether, these data show that adhesion of 
 
N.
 
 
 
men-
ingitidis
 
 to human endothelial cells induces tyrosine phos-
phorylation and clustering of ErbB2, but not of the other
ErbB members, suggesting that most likely 
 
N. meningitidis
 
induces ErbB2 activation by promoting the formation of
ErbB2 homodimers.
 
ErbB2 activation is not required for cortical plaque 
formation induced by 
 
N.
 
 
 
meningitidis
 
We have reported previously that 
 
N. meningitidis
 
 induces ac-
tin cytoskeleton rearrangements and cortical plaque forma-
tion in human endothelial cells (unpublished data). Since
stimulation of ErbBs may lead to Rho GTPase activation
Figure 2. Localized adhesion of N. meningitidis induces the 
tyrosyl phosphorylation of ErbB2, but not of the other ErbB members. 
HBMECs (starved for 24 h) were pretreated for 2 h with 5  M 
AG1478 ( ) or left untreated ( ). Cells were either noninfected 
(NT) or infected with the wild-type (WT), the PilT-defective mutant 
(PilT
 ) of the 2C43 strain, or the ROU strain of N. meningitidis, as 
indicated, for 4 h before lysis. AG1478 treatment was maintained 
during infection. As control, cells pretreated the same way were 
stimulated with 10 ng/ml EGF for 3 min before lysis. (A) EGF recep-
tor was immunoprecipitated and immunoblotted with an antiphos-
photyrosine antibody (4G10) (top). Blot was reprobed with an anti-
EGFR antibody (bottom) to show that similar levels of receptors 
were immunoprecipitated. (B and C) ErbB2 receptor was immuno-
precipitated and immunoblotted with an antiphosphotyrosine 
antibody (4G10) (top). Blots were reprobed with an anti-ErbB2 
antibody (bottom). Three independent experiments were carried 
out with similar results and representative results from one experi-
ment are shown.
Figure 3. Localized adhesion of N. meningitidis induces the 
clustering of ErbB2, but not of the other ErbB members. (A) Top, 
uninfected cells were stained for ErbB2; bottom, cells infected for
3 h with the 2C43 wild-type strain of N. meningitidis were double-
stained for ErbB2 (left) and bacterial colonies (middle). Merged 
images (overlay) of the same fields are presented on the right. (B) 
Cells infected for 3 h with the 2C43 wild-type strain of N. meningi-
tidis were double-stained for either EGFR, ErbB3, or ErbB4 (top, 
as indicated) and bacterial colonies (bottom). Panels show receptor 
and bacterial staining in the same fields. 
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and actin cytoskeleton rearrangements, we investigated the
contribution of ErbB2 activation in the HBMEC response
to 
 
N. meningitidis
 
. Immunofluorescence analysis of ezrin,
actin, and ErbB2 was performed in cells infected for 4 h
with the 2C43 wild-type strain of 
 
N. meningitidis
 
 in the
presence of 5 
 
 
 
M AG1478. As shown in Fig. 4 A, AG1478
did not prevent the massive recruitment of ezrin and cortical
actin polymerization underneath the bacterial colonies that
we described previously in the absence of inhibitor. This ob-
servation indicates that ErbB2 activation is not required for
cortical plaque formation induced by 
 
N. meningitidis
 
. More-
over, we observed that inhibition of ErbB2 activity did not
affect its own massive recruitment underneath the bacte-
rial colonies, thus suggesting that 
 
N. meningitidis–
 
induced
ErbB2 clustering may precede receptor activation.
Cellular localization of ErbB2 was then analyzed in the
presence of 30 
 
 
 
M Y27632, a selective inhibitor of the Rho
effector Rho-kinase (Ishizaki et al., 2000), which prevents
 
N. meningitidis
 
–induced
 
 
 
actin cytoskeleton rearrangement,
but does not affect ezrin recruitment underneath the bacte-
rial colonies (Fig. 4 B). Interestingly, Y27632 did not affect
either ErbB2 clustering (Fig. 4 B) or phosphorylation (un-
published data) induced by bacterial interaction. Therefore,
the Rho-GTPase–dependent cortical actin polymerization
induced by 
 
N. meningitidis
 
 is not required for ErbB2 recruit-
ment underneath the bacterial colonies or ErbB2 activation.
 
ErbB2 activation induced by N. meningitidis leads to 
the activation of the tyrosine kinase src and the 
subsequent phosphorylation of the src
substrate cortactin
To define the role of ErbB2 in the interaction process of N.
meningitidis with human endothelial cells, we attempted to
identify the tyrosyl-phosphorylated proteins p80/85 affected
by AG1478 treatment described in Fig. 1. The migration
pattern of p80/85 was suggestive of a few candidate proteins,
including the actin-binding protein cortactin, ezrin, and the
p85  subunit of the PI-3 kinase. Indeed, as shown in Fig. 5
A, infection for 4 h with the 2C43 wild-type strain of N.
Figure 4. ErbB2 activation is not required for cortical plaque 
formation induced by N. meningitidis. HBMECs were pretreated for 
2 h with 5  M AG1478 (A) or with 30  M Y27632 (B) before 
infection for 3 h with the 2C43 wild-type strain of N. meningitidis in 
the presence of the inhibitors. Cells were double-stained for ErbB2 
and bacterial colonies (top) or ezrin and actin (bottom). Merged 
images (overlay) of the same fields are presented on the right.
Figure 5. ErbB2 activation induced by N. meningitidis leads to src 
activation and the phosphorylation of cortactin. (A and B) HBMECs 
(starved for 18 h) were either uninfected ( ) or infected with the wild-
type (WT), the PilT-defective mutant (PilT
 ), or the PilE-defective 
mutant (PilE
 ) of the 2C43 strain of N. meningitidis for 4 h before lysis. 
(C–E) HBMECs starved for 18 h were pretreated for 2 h with either 5 
 M PP2 or 5  M AG1478 ( ) or left untreated ( ). Cells were either 
noninfected (NT) or infected with the wild-type 2C43 or the ROU 
strains as indicated for 4 h before lysis. PP2 and AG1478 treatments 
were maintained during infection. As control, cells pretreated the same 
way were stimulated with 10 ng/ml EGF for 3 min before lysis. (A, D, 
and E) Cortactin was immunoprecipitated and immunoblotted with an 
antiphosphotyrosine antibody (4G10) (top). Blots were reprobed with 
an anticortactin antibody (bottom) to show that similar protein levels 
were immunoprecipitated. (B and C) Src was immunoprecipitated and 
subjected to either an autophosphorylation assay (B) or an in vitro 
kinase assay using acid-denaturated enolase as a substrate (C). Three 
independent experiments were carried out with similar results and 
representative results from one experiment are shown.138 The Journal of Cell Biology | Volume 155, Number 1, 2001
meningitidis induced the tyrosyl phosphorylation of cortac-
tin, whereas ezrin or the p85  subunit of the PI-3 kinase
were not tyrosine phosphorylated under the same conditions
(unpublished data). In agreement with the fact that cortactin
is a known substrate of the tyrosine kinase src, an autophos-
phorylation assay demonstrated that src was indeed activated
in cells infected for 4 h with the 2C43 wild-type (Fig. 5 B).
As expected, no src activity nor tyrosyl phosphorylation of
cortactin was detected in cells in contact with the 2C43
PilE
  mutant, whereas the PilT
  mutant was more efficient
in inducing both src activity and cortactin phosphorylation.
Src activation induced by either 2C43 wild-type or ROU
strains of N. meningitidis was largely reduced by treatment
with 5  M AG1478 (Fig. 5 C). Moreover, cortactin phos-
phorylation was fully inhibited by a treatment with 5  M
PP2, a selective inhibitor of src family kinases (Fig. 5 D),
and was also largely inhibited by treatment with 5  M
AG1478 (Fig. 5 E), whereas EGF stimulation did not stimu-
late cortactin phosphorylation. Together, these results dem-
onstrate that N. meningitidis induces src activation and sub-
sequent cortactin phosphorylation and point to src as a
downstream signaling effector of ErbB2 in this pathway. In
addition, since AG1478 does not fully inhibit src activity
and cortactin phosphorylation, whereas it completely pre-
vents ErbB2 phosphorylation, an alternative pathway, inde-
pendent of ErbB2, may also contribute to the activation of
src induced by N. meningitidis.
Therefore, we examined whether src was associated with
phosphorylated ErbB2 in infected cells. As shown in Fig. 6
A, an increased amount of src was detected in ErbB2 immu-
noprecipitates in cells infected for 4 h with either the 2C43
wild-type or PilT
  mutant. These interactions were largely
prevented by treatment with 5  M AG1478, thus confirm-
ing that ErbB2 phosphorylation induced by N. meningitidis
results in the recruitment and activation of src. To further
confirm that bacteria- or EGF-induced ErbB2 phosphoryla-
tion can provide a docking site for the SH2 domain of
src, we performed a pull-down assay with a recombi-
nant gluthatione S-transferase (GST)–src SH2 fusion pro-
tein (Fig. 6, B and C). Analysis of the pattern of tyrosine-
phosphorylated proteins precipitated with the fusion protein
showed that both N. meningitidis and EGF induced the in-
teraction of src–SH2 with a 185-kD phosphoprotein identi-
fied by Western blotting as ErbB2, whereas only EGF stim-
ulation induced the interaction of src-SH2 with a prominent
tyrosine-phosphorylated band of 175 kD identified as EGFR.
These interactions were dependent on the intrinsic ki-
nase activity of ErbB2 or EGFR, since it was prevented by
AG1478 treatment. These observations confirmed our con-
clusion that, although EGF induced EGFR/ErbB2 het-
erodimerization, bacteria induced the clustering of ErbB2 as
homodimers.
Since cortactin is known to interact with actin, we as-
sessed whether cortactin was recruited at the site of actin po-
lymerization. Although cortactin displayed a generalized cy-
toplasmic staining with some enrichment in membrane
ruffles in uninfected cells, it was recruited in cortical plaques
in cells infected for 4 h with a the 2C43 wild-type strain of
N. meningitidis (Fig. 7). AG1478 and PP2 only slightly af-
fected cortactin recruitment into cortical plaques, which
was instead totally prevented by Y27632 treatment. Thus,
ErbB2 activation promotes cortactin phosphorylation, but
this event is not required for cortactin recruitment within
cortical plaques, a process dependent on cortactin interac-
tion with the actin cytoskeleton.
ErbB2/Src signaling pathway activation is involved in 
bacterial internalization by human endothelial cells
The internalization of N. meningitidis in endothelial cells, as
shown previously, is maximal during localized adhesion, i.e.,
when the ErbB2/src pathway is fully activated, as shown
here. The potential role of the ErbB2/src signaling pathway
on bacterial internalization into endothelial cells was there-
fore investigated. We observed that the 2C43 PilT
  mutant
and the ROU strain, which activate the ErbB2/src signaling
pathway more efficiently than the 2C43 wild-type strain,
were also more effectively internalized (2.5 and 10 , respec-
tively) (Fig. 8 A). As expected, no internalization of the non-
adherent PilE
  mutant was observed. Furthermore, treat-
ment with 5  M AG1478 or 5  M PP2 decreased bacterial
internalization by  50 or 70%, respectively (Fig. 8 B). In
agreement with our conclusion that src is a downstream sig-
naling effector of ErbB2, the addition of both inhibitors did
not further reduce bacterial entry. By contrast, AG1296, the
specific inhibitor of the PDGF receptor which failed to af-
Figure 6. Localized adhesion of N. meningitidis leads to src 
association with phosphorylated ErbB2. HBMECs (starved for 18 h) 
were either uninfected ( ) or infected with the wild-type (WT), or 
the PilT-defective mutant (PilT
 ) of the 2C43 strain of N. meningiti-
dis for 4 h before lysis. As control, cells pretreated the same way 
were stimulated with 10 ng/ml EGF for 3 min before lysis. (A) ErbB2 
was immunoprecipitated and immunoblotted with an anti-src anti-
body (top). Blot was reprobed with an anti-ErbB2 antibody (bottom) 
to show that similar protein levels were immunoprecipitated. (B and 
C) Whole cell extracts were incubated with 5  g of a GST-tagged 
peptide containing the SH2 domain of src and coupled to 
glutathione-Sepharose. The complexes were immunoblotted with 
an antiphosphotyrosine antibody (4G10) (top). Blots were reprobed 
with an anti-ErbB2 antibody (middle) and anti-EGFR antibody (bot-
tom). Three independent experiments were carried out with similar 
results and representative results from one experiment are shown.ErbB2 supports N. meningitidis invasion | Hoffmann et al. 139
fect the tyrosyl phosphorylation induced by N. meningitidis
(Fig. 1), had no effect on bacterial entry. Thus, these experi-
ments indicate that the ErbB2/src pathway is involved in N.
meningitidis internalization into endothelial cells.
Since we recently showed that the small Rho GTPases
were involved in cortical plaque formation and subsequent
N. meningitidis internalization into endothelial cells (unpub-
lished data), we analyzed the respective contributions of
both ErbB2/src and Rho GTPase–dependent signaling path-
ways on bacterial entry into endothelial cells. As shown in
Fig. 8 B, treatment with PP2 in the presence of Y27632 al-
most totally prevented bacterial entry (90% inhibition),
whereas Y27632 alone inhibited bacterial entry by 60%.
None of these treatments affected bacterial adhesion to en-
dothelial cells (unpublished data). Together, these data dem-
onstrate that N. meningitidis promotes two distinct signaling
pathways, the ErbB2/src and Rho-GTPase pathways, which
cooperate to promote N. meningitidis internalization into
endothelial cells.
Discussion
We have investigated here the tyrosine phosphorylation
events occurring during the interaction of N. meningitidis
with human endothelial cells. We demonstrate that the acti-
vation of the ErbB2 receptor tyrosine kinase is directly in-
volved in host signal transduction promoted by N. meningi-
tidis interaction and subsequent bacterial internalization.
N. meningitidis induces a massive recruitment and tyro-
sine phosphorylation of ErbB2. Our data suggest that the in-
teraction of N. meningitidis with human endothelial cells
leads to the activation of ErbB2, most likely via formation of
ErbB2 homodimers, since no recruitment nor tyrosine phos-
phorylation of any other known ErbB family members was
detected. We believe that these results constitute an impor-
tant finding since, although no soluble ligand for ErbB2 has
been identified so far, this receptor appears to be the pre-
ferred heterodimerization partner of all ErbB proteins (Tza-
har et al., 1996; Graus-Porta et al., 1997). Although the for-
mation of most heterodimers is mediated by ErbB ligands,
ErbB2-containing heterodimers may also be triggered by
other classes of receptors through ligand-independent path-
ways (Qiu et al., 1998). ErbB2 homodimerization was previ-
Figure 7. ErbB2 activation is not required for cortactin recruit-
ment within cortical plaques. Cells were pretreated for 2 h with 
either 5  M AG1478 or 30  M Y27632. Cells noninfected or 
infected for 3 h with the 2C43 wild-type strain of N. meningitidis 
were double-stained for ErbB2 (left) and cortactin (middle). Merged 
images (overlay) of the same fields are presented on the right.
Figure 8. (A) Entry levels of the different strains of N. meningitidis 
in HBMECs. HBMECs were infected with the wild-type (WT), the 
PilT-defective mutant (PilT
 ), or the PilE-defective mutant (PilE
 ) of 
the 2C43 strain of N. meningitidis. After 4 h, the number of internal-
ized bacteria in relation to the number of adherent bacteria was 
determined. (B) Effects of PP2, AG1478, AG1296, and Y27632 on 
N. meningitidis entry in HBMECs. Cells were either left untreated 
(NT) or pretreated for 2 h with 5  M PP2, 5  M AG1478, 5  M 
AG1296, 30  M Y27632, or with both inhibitors PP2 AG1478 or 
PP2 Y27632, as indicated. Cells were infected with the wild-type 
strain of N. meningitidis for 4 h in the presence of the inhibitors. The 
percentage of internalized bacteria in relation to the entry or 
adhesion of the wild-type strain in absence of any activator or 
inhibitor was determined, and average values ( SEM) from four 
independent experiments are presented.140 The Journal of Cell Biology | Volume 155, Number 1, 2001
ously described only in a few cases: a ligand-independent ac-
tivation of the kinase domain of ErbB2 is observed in a
significant proportion of breast and ovarian cancers overex-
pressing ErbB2, apparently as a result of spontaneous dimer
formation (Yarden and Sliwkowski, 2001). Homodimeriza-
tion of this receptor can also be achieved by mutating a
single amino acid residue in the transmembrane domain,
leading to constitutive ErbB2 dimerization and activation
(Bargmann et al., 1986; Olayioye et al., 1998). Alterna-
tively, antibody binding to the extracellular domain can also
promote ErbB2 homodimerization and its subsequent acti-
vation (Sarup et al., 1991; Olayioye et al., 1998). Thus, our
results constitute the first example of ErbB2 activation by
homodimerization induced in nontumor cells (expressing
physiological levels of ErbB2) through a ligand-independent
pathway.
ErbB2 activation by N. meningitidis infection apparently
results from bacteria-induced clustering of this receptor,
since ErbB2 tyrosine phosphorylation is dependent on its in-
trinsic kinase activity. In contrast, ErbB2 recruitment under-
neath the bacterial colonies appears to be activation-inde-
pendent, inasmuch as it was not affected by the ErbB2
kinase inhibitor AG1478. Clustering of ErbB2 may result in
the spontaneous homodimer formation due to an increased
local concentration of ErbB2 molecules, in a similar way to
what has been described in tumor cells overexpressing
ErbB2. Indeed, previous studies performed with antibody-
induced clustering of ErbB2 showed that the activation state
of ErbB2 correlates with the size of ErbB2 clusters (Nagy et
al., 1999). However, how N. meningitidis interaction leads
to ErbB2 clustering is still unclear. No activation of this sig-
naling pathway is observed in cells in contact with the non-
piliated strain of N. meningitidis (PilE
 ), thus indicating
that these events are not due to the presence of any bacterial-
secreted molecule in the infection medium. Moreover, this
activation is maximal during the localized adhesion of N.
meningitidis and decreases when bacteria loose their pili and
disperse at the cell surface, whereas it remains persistent in
cells infected with the PilT
  mutant. This mutant, defective
in pili retraction, is highly piliated and cannot disperse at the
cell surface (Pujol et al., 1999; Merz and So, 2000). Thus,
these data provide evidence that ErbB2 activation requires a
pilus-dependent interaction of the bacteria with the host
cells. Type IV pili initiate the interaction of virulent, capsu-
lated N. meningitidis with human cells by interacting with a
cellular receptor that remains to be clearly identified. The
membrane protein MCP/CD46 was suggested as a receptor
for N. meningitidis pili (Kallstrom et al., 1997). However the
weak affinity of the pili–CD46 interaction suggests the exist-
ence of an alternative human cell receptor for N. meningiti-
dis. Thus, ErbB2 clustering may result from a direct inter-
action with bacterial pili. Alternatively, ErbB2 might be
recruited underneath the bacterial colonies by interacting in
a multimer complex with other cellular components re-
cruited after interaction of bacteria with an unknown cellu-
lar receptor. Indeed, the evidence provided suggests that an
interaction between ErbB2 and other transmembrane glyco-
proteins may potentiate ErbB2 activation. In normal and
transformed mammary epithelial cells, the transmembrane
subunit of sialomucin complex ASGP-2 was shown to form
a stable complex through its EGF-like domain with ErbB2,
but not EGFR, ErbB3, or ErbB4, and to potentiate neureg-
ulin-induced ErbB2–ErbB3 heterodimer activation (Carr-
away et al., 1999). Moreover, a direct interaction between
CD44 and ErbB2 has been described, leading to a potentia-
tion of the constitutive tyrosine phosphorylation of ErbB2
in an ovarian carcinoma cell line overexpressing ErbB2
(Bourguignon et al., 1997), or to a significant increase in
neuregulin-induced ErbB2–ErbB3 heterodimerization and
ErbB2 phosphorylation in Schwann cells (Sherman et al.,
2000). Interestingly, we show here that ErbB2 was recruited
together with ezrin and CD44. Further studies are required
to assess whether such an interaction of ErbB2 with other
transmembrane glycoproteins may occur in endothelial cells
in response to N. meningitidis adhesion and may be critical
for bacteria-induced ErbB2 clustering and/or activation.
How does the activation of ErbB2 lead to the entry of N.
meningitidis into host cells that are normally nonphagocytic?
We showed that ErbB2 phosphorylation results in the re-
cruitment and activation of the tyrosine kinase src, which
are dependent on the intrinsic kinase activity of ErbB2. A se-
lective inhibition of both ErbB2 and src revealed a major
role of the ErbB2/src signaling in N. meningitidis internal-
ization. Interestingly, the ErbB2/src pathway is not required
for the activation of GTPase-dependent cytoskeletal modifi-
cations that we have observed recently in response to the ad-
hesion of N. meningitidis (unpublished data). Inhibition of
ErbB2 or src activity did not affect the cortical actin reorga-
nization induced underneath the bacterial colonies. In-
versely, inhibition of bacteria-induced cortical actin po-
lymerization did not prevent the activation of ErbB2/src
pathway. Therefore, N. meningitidis promotes the activation
of two distinct pathways, both of which contribute to an ef-
ficient internalization of bacteria. Interestingly, the implica-
tion in bacterial internalization of host cell src family tyro-
sine kinases and Rho family GTPases has been reported in
several cases of invasive pathogens (Dramsi and Cossart,
1998). For example, Opa52-mediated phagocytosis of N.
gonorrhoeae by human neutrophils requires, for an efficient
uptake, the activity of the related Rho family member Rac,
which appears to be controlled by an src-like tyrosine kinase
(Fgr or Hck) (Hauck et al., 1998). In the same way, src, to-
gether with Rho family GTPases, is involved in the internal-
ization of Shigella (Dehio et al., 1995; Adam et al., 1996)
and is required for triggering the formation of actin poly-
merization foci induced by Shigella (Dumenil et al., 1998).
By contrast, invasion by Salmonella, which requires the acti-
vation of Cdc42, probably does not involve tyrosine phos-
phorylation (Galan and Zhou, 2000). When required, tyro-
sine kinase activity is then directly involved in the activation
of small GTPases and controls bacterial entry by eliciting cy-
toskeleton changes. N. meningitidis seems to have developed
an alternative pathway leading to its subsequent uptake into
endothelial cells, since we observed that src tyrosine kinase
activity controls N. meningitidis entry at a different level
than Rho family GTPases. We showed that src activation by
N. meningitidis leads to the tyrosyl phosphorylation of a ma-
jor susbstrate (p80/85), which we identified as cortactin.
Cortactin is an actin-binding protein, which can promote in
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cortactin was highly recruited underneath the bacterial colo-
nies, and that this recruitment was not correlated with ty-
rosyl phosphorylation of cortactin, but was instead de-
pendent on cortical actin polymerization induced by N.
meningitidis. Interestingly, ErbB2 activation induced by
EGF, while activating src (unpublished data), did not lead to
cortactin phosphorylation. This apparent discrepancy may
result from the activation of specific signaling pathways acti-
vated by ErbB2 homodimers (in response to N. meningitidis)
or ErbB2/EGFR heterodimers (in response to EGF), includ-
ing the activation of alternative kinases involved in cortactin
phosphorylation, such as Fer (Kim and Wong, 1998). Alter-
natively, cortactin phosphorylation induced in infected cells
may result from the local concentration of signaling mole-
cules in microdomains underneath the bacterial colonies.
Further studies are required to investigate the consequences
of the tyrosyl phosphorylation of cortactin and to character-
ize the mechanism by which the src signaling pathway facili-
tates N. meningitidis internalization into endothelial cells.
In summary, these results, summarized in Fig. 9, provide
evidence for a novel mode of activation and an unsuspected
involvement of ErbB2 in host pathogen interaction. We be-
lieve that they will help unravel the pathophysiological
mechanism of meningitis associated with N. meningitidis in-
fection.
Materials and methods
Antibodies and reagents
Antibodies to cortactin (p80/85) and pp60
c-src were purchased from Up-
state Biotechnology; antiphosphotyrosine antibody (4G10) was from Med-
itech; polyclonal antibodies directed against EGFR, ErbB2, ErbB3, ErbB4
were purchased from Santa Cruz Biotechnology, Inc. Antiphospho Erk1/2
(Thr202/Tyr204) was from Cell Signaling Technology. Rhodamine phalloi-
din and recombinant human EGF were from Sigma-Aldrich. GST fusion
protein containing src-SH2 domain was provided by Dr. S. Fisher (Institut
Cochin de Génétique Moléculaire, Paris, France). The selective inhibitors
AG1478, AG1296, and PP2 were from Calbiochem, and Y27632 was pro-
vided by Yoshitomi Pharmaceutical.
Bacterial strains and growth conditions
2C43 (formerly clone 12), a piliated capsulated Opa
  variant of the sero-
group C meningococcal strain 8013, the nonpiliated derivative strain pilE::
Km, and the PilT
  derivative strain pilT::Erm were described previously
(Nassif et al., 1993; Pujol et al., 1999). The strain designated ROU (group
W135, ET37), is a piliated, capsulated isolate obtained from the cere-
brospinal fluid of a 2-mo-old infant and has been described previously
(Pron et al., 1997). Before experiments, N. meningitidis was grown over-
night on GCB solid medium (4% GC medium base; Difco), 1% agar, 0.4%
glucose, 0.2 mg/ml thiamine, 0.0005% Fe(NO3)39H2O, 0.01% L-glutamine
at 37 C under 5% CO2. Several colonies were then selected and grown in
DME supplemented with 0.1% BSA for 2 h and were finally diluted to
 10
7 bacteria/ml suspension for cell infection.
Cell culture, infection, and quantification of N. meningitidis 
adhesion or entry into endothelial cells
HBMECs (Schweitzer et al., 1997), provided by Dr. B. Weksler (Weill
Medical College of Cornell University, Ithaca, NY), were cultured in DME
Glutamax (Life Technologies) supplemented with 10% heat-inactivated fe-
tal bovine serum, 7.5  g/ml endothelial cell growth supplement (Sigma-
Aldrich), 7 UI heparin (Sigma-Aldrich) and 10 mM Hepes.
Infections were performed as follows: confluent monolayers of HBMECs
were starved for 18 h before infection in DME supplemented with 0.1%
BSA (starvation medium) to lower the basal level of tyrosine phosphoryla-
tions. HBMECs were then overlaid for 30 min with  10
7 bacteria in starva-
tion medium. Cells were then washed three times with starvation medium
to remove nonadherent bacteria and infection was allowed to proceed for
various periods of time. To avoid reinfection of the monolayers, cells were
washed once every hour with starvation medium. When indicated, cells
were pretreated for 2 h with AG1478, AG1296, PP2, or Y27632 before in-
fection. Cells were then infected as above and the infection was allowed to
proceed for 4 h in the presence of the inhibitors. For adhesion and inter-
nalization assays, cells grown to confluency in 6-well plates were infected
in starvation medium, washed three times, and the infection was allowed
Figure 9. Schematic representation of 
the signaling pathways activated by N. 
meningitidis and involved in bacterial en-
try into endothelial cells. (1) Type IV pili 
initiate the interaction of virulent, capsu-
lated N. meningitidis with human endo-
thelial cells by interacting with a cellular 
receptor that remains to be clearly identi-
fied. Bacteria then proliferate, locally 
forming a colony at their site of attach-
ment on the cell surface. (2) This pili-
dependent adhesion induces, through a 
Rho GTPase-independent pathway, the 
recruitment of ezrin and moesin, two 
proteins that link the cellular membrane 
to the actin cytoskeleton, and the cluster-
ing of several transmembrane proteins: 
ErbB2 and the ezrin binding proteins 
CD44 and ICAM-1. (3) The activation of 
both Rho and Cdc42 GTPases induces a 
localized polymerization of cortical 
actin, leading to the formation of mem-
brane projections reminiscent of epithelial 
microvilli structures, which surround 
single bacteria and provoke their internal-
ization within endothelial intracellular 
vacuoles. Downstream of bacteria-
induced ErbB2 activation are the ras/
MAPK signaling pathway, and the src ty-
rosine kinase which phosphorylates cort-
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to proceed for 4 h. To quantify adherent bacteria, the infected cell layers
were extensively washed, resuspended by scraping into GCB liquid me-
dium, serially diluted, and spread onto GCB plates. Bacteria were grown
overnight and colony-forming units were counted. To quantify internalized
bacteria, the infected cell layers were extensively washed, incubated with
150  g/ml gentamicin at 37 C for 1 h, and washed extensively before
scraping and plating dilutions onto GCB plates. Each condition was per-
formed in triplicate and each experiment was carried out four times inde-
pendently.
Immunoprecipitations and immunoblotting
Cells were washed once with cold PBS and lysed in a NP-40–based buffer
(0.1% NP-40, 50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 5 mM EDTA, 2
mM NaVO4, 5 mM NaF, 1 mM PMSF, 10  g/ml each of aprotinin/leupep-
tin/pepstatin). For the coimmunoprecipitation assay, cells were lysed in a
Triton X-100–containing buffer (1% Triton X-100, 50 mM Tris-HCl, pH
7.4, 150 mM NaCl, 10% glycerol, 1 mM MgCl2, 1 mM CaCl2, 2 mM
NaVO4, 5 mM NaF, 1 mM PMSF, 10  g/ml each of aprotinin/leupeptin/
pepstatin). The insoluble fraction was removed by centrifugation and the
cleared lysates were used for immunoprecipitation with specific antibodies
or pull down experiment with the GST fusion protein. Precipitated proteins
or fractions of the whole cell lysate were separated on a 7.5% SDS-PAGE
gel and transferred to nitrocellulose (Schleicher & Schuell). After blocking
for 1 h in PBS/1% BSA/0.05% Tween 20, filters were probed overnight
with specific antibodies. Proteins were visualized with peroxidase-coupled
secondary antibody using the ECL system (Amersham Pharmacia Biotech).
Src autophosphorylation/kinase assays
Immunoprecipitation of src was carried out as described in the previous
section, using anti-p60
c-src antibody and protein G–Sepharose beads. Beads
were washed three times in an autophosphorylation buffer (20 mM Pipes,
pH 7, 10 mM MnCl2, 1 mM PMSF, 0.1 mM NaVO4, 2  g/ml aprotinin/leu-
peptin/pepstatin). Beads were resuspended in autophosphorylation buffer
and incubated for 5 min at 30 C with 1  M ATP and 25  Ci 
32P ATP. Alter-
natively, beads were washed three times in an enolase buffer (100 mM
Pipes, pH 7, 10 mM MnCl2, 1 mM PMSF, 0.1 mM NaVO4, 2  g/ml aproti-
nin/leupeptin/pepstatin) and incubated for 5 min at 30 C with 3  M ATP,
25  Ci 
32P ATP, and 5  g of denatured enolase (5 min at 30 C in 25 mM
acetate buffer, pH 3.3). Reactions were stopped with Laemmli’s buffer.
Samples were heated for 10 min at 100 C, separated by electrophoresis on
a 12% SDS-polyacrylamide gel, and transferred to nitrocellulose mem-
branes. Incorporations of radioactive ATP by src ro enolase were detected
by autoradiography.
Confocal immunofluorescence microscopy
HBMECs were grown to confluence on Permanox chamber slides (Lab-
Tek). After infection, cells were fixed in 4% paraformaldehyde for 10 min,
washed three times with PBS, and permeabilized with 0.2% Triton X-100
in PBS for 10 min. Cells were blocked for 30 min with 3% BSA in PBS and
were incubated for 2 h with the primary antibodies. After three washes
with PBS, cells were incubated for 1 h with CY3-conjugated anti–mouse
IgG and CY2-conjugated anti–rabbit IgG (Jackson ImmunoResearch Labo-
ratories). Actin staining was performed with rhodamine-labeled phalloidin
(Sigma-Aldrich) and bacteria staining with 0.5  g/ml ethidium bromide.
Labeled preparations were mounted in mowiol and analyzed with a confo-
cal microscope (Bio-Rad Laboratories).
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